The weekly litigation news digest is live. Subscribe now

IP Verse

Jumpcode Genomics competitive analysis

Loading summary...

Latest oppositions filed by Jumpcode Genomics

Explore patent oppositions filed by Jumpcode Genomics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3234200
Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System ProteinsARC BIOApr 7, 2022
EP3105325
Methods Of Depleting A Target Molecule From An Initial Collection Of Nucleic Acids, And Compositions And Kits For Practicing The SameTAKARA BIO USASep 4, 2020

Latest patents of Jumpcode Genomics opposed by its competitors

Explore Jumpcode Genomics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3102722
Aug 26, 2020Genome Fractioning1

Latest PTAB cases involving Jumpcode Genomics

Discover the latest PTAB cases involving Jumpcode Genomics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Jumpcode Genomics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JUMPCODE GENOMICS21 - -
ARC BIO - 1 - -
TAKARA BIO USA11 - -